Charles River Laboratories International, Inc. (CRL)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EST
Pre-market:
| Previous close | 200.61 |
| Open | 199.28 |
| Bid | 0.00 x 1800 |
| Ask | 0.00 x 800 |
| Day's range | 196.00 - 199.28 |
| 52-week range | 161.65 - 262.00 |
| Volume | |
| Avg. volume | 535,958 |
| Market cap | 10.291B |
| Beta (5Y monthly) | 1.37 |
| PE ratio (TTM) | 21.75 |
| EPS (TTM) | 9.12 |
| Earnings date | 20 Feb 2024 - 26 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 211.04 |
ZacksHere's Why You Should Retain Charles River (CRL) Stock Now
Charles River's (CRL) share price is likely to grow, backed by the strength of the DSA segment.
GuruFocus.comInsider Sell: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)
Joseph Laplume, the Executive Vice President of Corporate Strategy & Development at Charles River Laboratories International Inc (NYSE:CRL), has recently sold 1,850 shares of the company's stock.
ZacksCharles River (CRL) Backs the Quest to Cure SPG56 via New Deal
Charles River (CRL) and GC4K announce a gene therapy manufacturing collaboration.
© 2023 Yahoo. All rights reserved.